By the end of 2018, through 10 years of continuous research and development, we have successfully developed : Small molecule targeted anti-tumor products: 21 projects ,such as Gefitinib, Erlotinib, Pazopanib, Lapatinib, Afatinib, Lenvatinib,etc; Diabetes products: 16 items ,such as Sitagliptin, Linagliptin,Alogliptin, Dapagliflozin, and Canagliflozin,etc; Anti-Cardiovascular products: 7 projects ,including Apixaban, Rivaroxaban, Betrixaban, and Dofetilide;
ANQING CHICO PHARMACEUTICAL CO.,LTD.
Country: 
China (Mainland)
Business Type: Trading Company
Premiumsupplier
Ms.JIANG
Tel: +86-13057662806
methyl 5-fluoro-2-methyl-3-nitro-benzoateCAS NO.: 697739-03-0
1-Chloro-2-[(4-ethoxyphenyl)methyl]-4-iodobenzeneCAS NO.: 1103738-29-9
Nintedanib EsylateCAS NO.: 656247-18-6
P-[2-[[4-[(3-Chloro-4-fluorophenyl)amino]-7-[[(3S)-tetrahydro-3-furanyl]oxy]-6-quinazolinyl]amino]-2-oxoethyl]phosphonic acid diethyl esterCAS NO.: 618061-76-0
N-(2-chloropyriMidin-4-yl)-N,2,3-triMethyl-2H-indazol-6-aMineCAS NO.: 444731-75-3
3-Formyl-2-nitrobenzoic acid methyl esterCAS NO.: 138229-59-1
N-(3-Chloro-4-fluorophenyl)-6-nitro-7-[[(3S)-tetrahydro-3-furanyl]oxy]-4-quinazolinamineCAS NO.: 314771-88-5
2-AMino-N-(5-chloropyridin-2-yl)-5-MethoxybenzaMideCAS NO.: 280773-17-3
6-Cyano-2-[1-(4-ethyl-3-iodophenyl)-1-methylethyl]-1H-indole-3-carboxylic acid 1,1-dimethylethyl esterCAS NO.: 1256584-75-4
1-(Cyclopropylcarbonyl)piperazine hydrochlorideCAS NO.: 1021298-67-8
